Indian Filmmakers Brace for US Market Loss

In the brightly lacquered hallway of international cinema, Indian films have always worn their glitter a little too loud and their hearts a little too close to the surface for Western critics to take them seriously. For decades, they’ve been cataloged as diaspora comfort food—glossy, melodious, faintly overacted affairs that were charming as long as they stayed politely out of the awards circuit.

That calculus has been quietly imploding. Starting somewhere around the global earthquake of Baahubali 2: The Conclusion—which in 2017 grossed over $20 million at the North American box office, making it not just the highest-grossing Indian film in the US but a kind of mythopoetic arrow through the heart of Western franchise fatigue—there has been a slow, steady recalibration.

By the time RRR came thundering across Dolby screens in the American heartland in 2022, drawing midnight audiences who hadn’t heard the word “Tollywood” before, Indian cinema had become something of a Trojan horse in Hollywood’s backyard. RRR amassed approximately $14.9 million in North America, signalling a significant shift in the global cinematic landscape.

Now, with Trump 2.0 unveiling a 100% tariff on foreign-produced films, it looks like the horse is about to be torched at the gates. The announcement was made on May 5, 2025: a flat 100% tariff on all non-American films entering the U.S., citing “national security” and “the need to protect our great American film industry from foreign distortion.”

The irony, of course, is that America already dominates the global film market like no other, flooding territories with so much content that regional industries are forced into aesthetic compromise or extinction. What this tariff really threatens is not cultural infiltration, but cultural reciprocity—a shared oxygen of storytelling across borders. For Indian cinema—which in recent years earned over $100 million from US theatres alone—this is not just a bruise; it’s a gut punch.

To understand what’s at stake, rewind for a moment to the era before Baahubali, when the primary logic of releasing Indian films in America was one of diaspora outreach. A Shah Rukh Khan romance would open in New Jersey and Fremont and Edison, not because Americans wanted it, but because Indians did. It was a niche business, albeit a fairly profitable one. In 2010, for instance, My Name is Khan scraped together a respectable $4 million in the US.

Then came Baahubali 2. And later, KGF: Chapter 2, Pathaan, Jawan, Kantara, Pushpa: The Rise, Leo, Kalki 2898 AD. These weren’t just hits among Indian expats; they were crossover events. The Telugu film RRR made over $14.9 million theatrically in the U.S. alone—and far more through subsequent digital and awards buzz. It wasn’t engineered for American tastes. It didn’t pander. And that was the point. Audiences came for its maximalism, its moral clarity, its tiger-fighting musical numbers. It offered everything that Hollywood, lately preoccupied with depressive antiheroes and washed-out palette grittiness, had forgotten: delight, consequence, physicality.

The Trump tariff arrives at a moment when Indian cinema has cracked the code: don’t imitate, amplify. And it threatens to unravel all of that. Because now, every distributor bringing in a major Indian film—Tamil, Telugu, Hindi, Malayalam—will face either a price hike that makes box office recoupment impossible or a strategic withdrawal from theatrical releases in the U.S. altogether. Ticket prices could double. Some projections suggest a $15 weekday ticket could become $30, putting it squarely out of impulse-buy territory. Theatres may drop Indian titles entirely. Even the diehards, the ones who’d drive two hours to catch Singham Again in a suburban strip mall, might begin to falter.

Streaming platforms, at least in theory, offer an escape route. But if the tariff is enforced broadly—if it extends not just to physical prints but digital rights and licensing agreements—then the Netflixes and Amazons of the world will also have to think twice before snapping up Indian blockbusters for the US library.

Some have argued the blow will be symbolic, not surgical. That only 5–7% of a film’s revenue comes from the US, and that the Indian market—now the largest in ticket volume globally—will compensate. But this forgets how prestige, buzz, and international reviews play into a film’s long tail. A successful US run translates into wider streaming deals, festival selections, and, crucially, the possibility of second lives—dubbed, subtitled, even adapted. Indian cinema, long dismissed as melodramatic excess, was beginning to be treated seriously—as vision, not kitsch. This is not about dollars alone. It’s about aesthetic legitimacy.

It’s also about class. In India, global success is often a social validator. That RRR could make the rounds at the Oscars and get reviewed abroad meant something. Indian filmmakers were no longer supplicants at the altar of Hollywood approval—they were players in the same league, sometimes even disruptors. A 100% tariff is not just a financial wall—it is a psychic one.

And yet. Perhaps, perversely, this moment might force the Indian film industry to double down on its own terms. To stop chasing international validation and start exporting unapologetically local stories. There’s precedent. Korean cinema never needed to be coddled by Hollywood to become a global juggernaut. Iranian films win hearts and prizes without studio backing. Maybe Indian cinema will now have to evolve new circuits, new pipelines. Europe, Southeast Asia, Africa. Maybe this is a reminder that America, for all its gravity, is not the only planet in the cultural solar system.

Baahubali 2Donald Trumpglobal businessIndian cinemaNews BriefPathaanRRRtrade tariffUS import tariffWeb Exclusive